HALEY KERSHNER: Open Payments
NPI 1306517354 · EPHRATA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 11 payments from 6 companies in 2025. Trend: 2023 $528 · 2024 $670 · 2025 $238
Food & beverage: $238
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Celltrion USA Inc. | 2 | $44 |
| Ardelyx, Inc. | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $20 |
Products named: ENTYVIO, VEGZELMA, RINVOQ, IBSRELA, XIFAXAN, SKYRIZI, TREMFYA, LINZESS.
Industry payments across PA — which companies pay providers there.
